Inventor

SILVERMAN JEFFREY A

US7 patents

⚠️ This page may combine multiple inventors who share the name “SILVERMAN JEFFREY A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SUNESIS PHARMACEUTICALS INC

3 patents

US7989468B2Aug 2, 2011

ADELMAN DANIEL C

3 patents

US8124773B2Feb 28, 2012

1,8-naphthyridine compounds for the treatment of cancer

ADELMAN DANIEL C10 citations78

US8580814B2Nov 12, 2013

Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4- oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancer

ADELMAN DANIEL C3 citations58

US8765954B2Jul 1, 2014

1,8-naphthyridine compounds for the treatment of cancer

ADELMAN DANIEL C1 citations57

SILVERMAN JEFFREY A

1 patent

US8518872B2Aug 27, 2013

Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-OXO-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid in combination therapy

SILVERMAN JEFFREY A4 citations54

SILVERMAN JEFFREY A

SUNESIS PHARMACEUTICALS INC

Methods of using SNS-595

SNS-595 and methods of using the same

Compounds and compositions for treatment of cancer

ADELMAN DANIEL C

1,8-naphthyridine compounds for the treatment of cancer

Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4- oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancer

1,8-naphthyridine compounds for the treatment of cancer

SILVERMAN JEFFREY A

Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-OXO-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid in combination therapy